Raising Long-Term Growth Capital in London (hosted by Premier Member, Penningtons Manches)

London's equity capital markets, including the Alternative Investment Market (AIM), have seen a surge in popularity from not just UK but also international issuers in the recent past and are a viable source of stable, long-term institutional capital for many growth businesses. Indeed, London is home to more than 50 US-based companies, including life science related companies such as Verseon, PureTech and recent addition Maxcyte.
 
Join us for a breakfast seminar and panel discussion with leading experts from the London Stock Exchange, KPMG and Penningtons Manches to hear more about current equity issuance conditions and the opportunities London can offer UK, US and international growth companies, where we will also be joined by senior management from Verseon, which executed a $100m IPO on AIM just over a year ago, to hear their experiences of listing on AIM.

Please register here.